Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Vascular Phenotyping and Target-Organ Damage Using Vascular Imaging, Glyco-Oxidative Biomarkers, and Photoplethysmography in Adults at Increased Cardiovascular Risk: The GlycOxiTOD Observational Registry

NCT06325800 is registered in ClinicalTrials.gov with Complejo Hospitalario Universitario de Santiago as lead sponsor.

NCT NCT06325800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06325800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Vascular Phenotyping and Target-Organ Damage Using Vascular Imaging, Glyco-Oxidative Biomarkers, and Photoplethysmography in Adults at Increased Cardiovascular Risk: The GlycOxiTOD Observational Registry
Lead sponsor
Complejo Hospitalario Universitario de Santiago
Phase
Observational
Overall status
Recruiting
Start date
January 10, 2024
Completion date
December 31, 2035
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, heart disease risk factors, hypertension, target organ damage, vascular stiffness